Wall Street Zen upgraded shares of Quantum-Si (NASDAQ:QSI – Free Report) from a sell rating to a hold rating in a report published on Saturday,Wall Street Zen reports.
Other equities analysts have also issued reports about the company. Alliance Global Partners reissued a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Weiss Ratings cut Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, September 9th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $1.00.
View Our Latest Stock Report on QSI
Quantum-Si Stock Performance
Quantum-Si (NASDAQ:QSI – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. The firm had revenue of $0.34 million during the quarter, compared to the consensus estimate of $0.30 million. As a group, analysts forecast that Quantum-Si will post -0.47 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the company. Renaissance Technologies LLC bought a new stake in shares of Quantum-Si during the 1st quarter worth $91,000. WINTON GROUP Ltd purchased a new position in shares of Quantum-Si in the 2nd quarter worth about $67,000. Green Alpha Advisors LLC bought a new position in shares of Quantum-Si during the 2nd quarter valued at about $41,000. Corient Private Wealth LP bought a new position in shares of Quantum-Si during the 2nd quarter valued at about $34,000. Finally, Hollencrest Capital Management raised its holdings in shares of Quantum-Si by 301.1% during the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after buying an additional 30,111 shares in the last quarter. 39.90% of the stock is currently owned by hedge funds and other institutional investors.
Quantum-Si Company Profile
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Further Reading
- Five stocks we like better than Quantum-Si
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
